Together with other findings showing that iron chelators could induce cell death regardless of MYCN status [48] and the fact that MYCN/C-MYC is still unable to be targeted, MYCN is an important clinical marker, but may not be a necessary direct target for the treatment of neuroblastoma. Here, MYC is linked to neuroblastoma.